SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043998
Filing Date
2021-08-12
Accepted
2021-08-12 16:21:21
Documents
85
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-10q_20210630.htm   iXBRL 10-Q 2952645
2 EX-31.1 fdmt-ex311_6.htm EX-31.1 24672
3 EX-31.2 fdmt-ex312_7.htm EX-31.2 24728
4 EX-32.1 fdmt-ex321_8.htm EX-32.1 10921
  Complete submission text file 0001564590-21-043998.txt   9688174

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20210630.xsd EX-101.SCH 74453
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fdmt-20210630_cal.xml EX-101.CAL 36556
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fdmt-20210630_def.xml EX-101.DEF 240352
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20210630_lab.xml EX-101.LAB 483858
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20210630_pre.xml EX-101.PRE 393365
10 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-10q_20210630_htm.xml XML 1689316
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 211167877
SIC: 2836 Biological Products, (No Diagnostic Substances)